T-Cell Therapies for Epstein-Barr Virus–Associated Lymphomas

Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome

(2011) Kitsada Wudhikarn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Sobering realities of surviving Hodgkin Lymphoma

(2011) K. Dunleavy et al.   BLOOD

Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein–Barr virus-associated lymphoma

(2011) Catherine M. Bollard et al.   CYTOTHERAPY

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

(2010) J. N. Barker et al.   BLOOD

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

(2010) C. P. Fox et al.   BLOOD

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects

(2010) J. J. Melenhorst et al.   BLOOD

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

(2010) A. Moosmann et al.   BLOOD

Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

(2010) Irene Cavattoni et al.   LEUKEMIA & LYMPHOMA

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

(2009) J. Brewin et al.   BLOOD

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

(2009) B. De Angelis et al.   BLOOD

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation

(2009) Michael Uhlin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

(2008) Catherine M. Bollard et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

(2007) Adrian J.C. Bloor et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION